IBDEI11G ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16879,0)
;;=J11.1^^61^777^47
;;^UTILITY(U,$J,358.3,16879,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16879,1,3,0)
;;=3^Influenza d/t Unident Influenza Virus w/ Oth Resp Manifest
;;^UTILITY(U,$J,358.3,16879,1,4,0)
;;=4^J11.1
;;^UTILITY(U,$J,358.3,16879,2)
;;=^5008158
;;^UTILITY(U,$J,358.3,16880,0)
;;=N12.^^61^777^92
;;^UTILITY(U,$J,358.3,16880,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16880,1,3,0)
;;=3^Tubulo-Interstitial Nephritis
;;^UTILITY(U,$J,358.3,16880,1,4,0)
;;=4^N12.
;;^UTILITY(U,$J,358.3,16880,2)
;;=^5015575
;;^UTILITY(U,$J,358.3,16881,0)
;;=N11.9^^61^777^93
;;^UTILITY(U,$J,358.3,16881,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16881,1,3,0)
;;=3^Tubulo-Interstitial Nephritis,Chronic
;;^UTILITY(U,$J,358.3,16881,1,4,0)
;;=4^N11.9
;;^UTILITY(U,$J,358.3,16881,2)
;;=^5015574
;;^UTILITY(U,$J,358.3,16882,0)
;;=N13.6^^61^777^78
;;^UTILITY(U,$J,358.3,16882,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16882,1,3,0)
;;=3^Pyonephrosis
;;^UTILITY(U,$J,358.3,16882,1,4,0)
;;=4^N13.6
;;^UTILITY(U,$J,358.3,16882,2)
;;=^101552
;;^UTILITY(U,$J,358.3,16883,0)
;;=N30.91^^61^777^22
;;^UTILITY(U,$J,358.3,16883,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16883,1,3,0)
;;=3^Cystitis w/ Hematuria,Unspec
;;^UTILITY(U,$J,358.3,16883,1,4,0)
;;=4^N30.91
;;^UTILITY(U,$J,358.3,16883,2)
;;=^5015643
;;^UTILITY(U,$J,358.3,16884,0)
;;=N30.90^^61^777^23
;;^UTILITY(U,$J,358.3,16884,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16884,1,3,0)
;;=3^Cystitis w/o Hematuria,Unspec
;;^UTILITY(U,$J,358.3,16884,1,4,0)
;;=4^N30.90
;;^UTILITY(U,$J,358.3,16884,2)
;;=^5015642
;;^UTILITY(U,$J,358.3,16885,0)
;;=N41.9^^61^777^41
;;^UTILITY(U,$J,358.3,16885,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16885,1,3,0)
;;=3^Inflammatory Disease of Prostate,Unspec
;;^UTILITY(U,$J,358.3,16885,1,4,0)
;;=4^N41.9
;;^UTILITY(U,$J,358.3,16885,2)
;;=^5015694
;;^UTILITY(U,$J,358.3,16886,0)
;;=N70.91^^61^777^80
;;^UTILITY(U,$J,358.3,16886,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16886,1,3,0)
;;=3^Salpingitis,Unspec
;;^UTILITY(U,$J,358.3,16886,1,4,0)
;;=4^N70.91
;;^UTILITY(U,$J,358.3,16886,2)
;;=^5015806
;;^UTILITY(U,$J,358.3,16887,0)
;;=N70.93^^61^777^79
;;^UTILITY(U,$J,358.3,16887,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16887,1,3,0)
;;=3^Salpingitis & Oophoritis,Unspec
;;^UTILITY(U,$J,358.3,16887,1,4,0)
;;=4^N70.93
;;^UTILITY(U,$J,358.3,16887,2)
;;=^5015808
;;^UTILITY(U,$J,358.3,16888,0)
;;=N70.92^^61^777^58
;;^UTILITY(U,$J,358.3,16888,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16888,1,3,0)
;;=3^Oophoritis,Unspec
;;^UTILITY(U,$J,358.3,16888,1,4,0)
;;=4^N70.92
;;^UTILITY(U,$J,358.3,16888,2)
;;=^5015807
;;^UTILITY(U,$J,358.3,16889,0)
;;=N73.9^^61^777^40
;;^UTILITY(U,$J,358.3,16889,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16889,1,3,0)
;;=3^Inflammatory Disease Female Pelvic,Unspec
;;^UTILITY(U,$J,358.3,16889,1,4,0)
;;=4^N73.9
;;^UTILITY(U,$J,358.3,16889,2)
;;=^5015820
;;^UTILITY(U,$J,358.3,16890,0)
;;=A56.11^^61^777^39
;;^UTILITY(U,$J,358.3,16890,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16890,1,3,0)
;;=3^Inflammatory Disease Chlamydial Female Pelvic
;;^UTILITY(U,$J,358.3,16890,1,4,0)
;;=4^A56.11
;;^UTILITY(U,$J,358.3,16890,2)
;;=^5000342
;;^UTILITY(U,$J,358.3,16891,0)
;;=N73.5^^61^777^67
;;^UTILITY(U,$J,358.3,16891,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI11G 3770 printed Sep 23, 2025@19:35:54 Page 2
IBDEI11G ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16879,0)
+2 ;;=J11.1^^61^777^47
+3 ;;^UTILITY(U,$J,358.3,16879,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,16879,1,3,0)
+6 ;;=3^Influenza d/t Unident Influenza Virus w/ Oth Resp Manifest
+7 ;;^UTILITY(U,$J,358.3,16879,1,4,0)
+8 ;;=4^J11.1
+9 ;;^UTILITY(U,$J,358.3,16879,2)
+10 ;;=^5008158
+11 ;;^UTILITY(U,$J,358.3,16880,0)
+12 ;;=N12.^^61^777^92
+13 ;;^UTILITY(U,$J,358.3,16880,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,16880,1,3,0)
+16 ;;=3^Tubulo-Interstitial Nephritis
+17 ;;^UTILITY(U,$J,358.3,16880,1,4,0)
+18 ;;=4^N12.
+19 ;;^UTILITY(U,$J,358.3,16880,2)
+20 ;;=^5015575
+21 ;;^UTILITY(U,$J,358.3,16881,0)
+22 ;;=N11.9^^61^777^93
+23 ;;^UTILITY(U,$J,358.3,16881,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,16881,1,3,0)
+26 ;;=3^Tubulo-Interstitial Nephritis,Chronic
+27 ;;^UTILITY(U,$J,358.3,16881,1,4,0)
+28 ;;=4^N11.9
+29 ;;^UTILITY(U,$J,358.3,16881,2)
+30 ;;=^5015574
+31 ;;^UTILITY(U,$J,358.3,16882,0)
+32 ;;=N13.6^^61^777^78
+33 ;;^UTILITY(U,$J,358.3,16882,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,16882,1,3,0)
+36 ;;=3^Pyonephrosis
+37 ;;^UTILITY(U,$J,358.3,16882,1,4,0)
+38 ;;=4^N13.6
+39 ;;^UTILITY(U,$J,358.3,16882,2)
+40 ;;=^101552
+41 ;;^UTILITY(U,$J,358.3,16883,0)
+42 ;;=N30.91^^61^777^22
+43 ;;^UTILITY(U,$J,358.3,16883,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,16883,1,3,0)
+46 ;;=3^Cystitis w/ Hematuria,Unspec
+47 ;;^UTILITY(U,$J,358.3,16883,1,4,0)
+48 ;;=4^N30.91
+49 ;;^UTILITY(U,$J,358.3,16883,2)
+50 ;;=^5015643
+51 ;;^UTILITY(U,$J,358.3,16884,0)
+52 ;;=N30.90^^61^777^23
+53 ;;^UTILITY(U,$J,358.3,16884,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,16884,1,3,0)
+56 ;;=3^Cystitis w/o Hematuria,Unspec
+57 ;;^UTILITY(U,$J,358.3,16884,1,4,0)
+58 ;;=4^N30.90
+59 ;;^UTILITY(U,$J,358.3,16884,2)
+60 ;;=^5015642
+61 ;;^UTILITY(U,$J,358.3,16885,0)
+62 ;;=N41.9^^61^777^41
+63 ;;^UTILITY(U,$J,358.3,16885,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,16885,1,3,0)
+66 ;;=3^Inflammatory Disease of Prostate,Unspec
+67 ;;^UTILITY(U,$J,358.3,16885,1,4,0)
+68 ;;=4^N41.9
+69 ;;^UTILITY(U,$J,358.3,16885,2)
+70 ;;=^5015694
+71 ;;^UTILITY(U,$J,358.3,16886,0)
+72 ;;=N70.91^^61^777^80
+73 ;;^UTILITY(U,$J,358.3,16886,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,16886,1,3,0)
+76 ;;=3^Salpingitis,Unspec
+77 ;;^UTILITY(U,$J,358.3,16886,1,4,0)
+78 ;;=4^N70.91
+79 ;;^UTILITY(U,$J,358.3,16886,2)
+80 ;;=^5015806
+81 ;;^UTILITY(U,$J,358.3,16887,0)
+82 ;;=N70.93^^61^777^79
+83 ;;^UTILITY(U,$J,358.3,16887,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,16887,1,3,0)
+86 ;;=3^Salpingitis & Oophoritis,Unspec
+87 ;;^UTILITY(U,$J,358.3,16887,1,4,0)
+88 ;;=4^N70.93
+89 ;;^UTILITY(U,$J,358.3,16887,2)
+90 ;;=^5015808
+91 ;;^UTILITY(U,$J,358.3,16888,0)
+92 ;;=N70.92^^61^777^58
+93 ;;^UTILITY(U,$J,358.3,16888,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,16888,1,3,0)
+96 ;;=3^Oophoritis,Unspec
+97 ;;^UTILITY(U,$J,358.3,16888,1,4,0)
+98 ;;=4^N70.92
+99 ;;^UTILITY(U,$J,358.3,16888,2)
+100 ;;=^5015807
+101 ;;^UTILITY(U,$J,358.3,16889,0)
+102 ;;=N73.9^^61^777^40
+103 ;;^UTILITY(U,$J,358.3,16889,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,16889,1,3,0)
+106 ;;=3^Inflammatory Disease Female Pelvic,Unspec
+107 ;;^UTILITY(U,$J,358.3,16889,1,4,0)
+108 ;;=4^N73.9
+109 ;;^UTILITY(U,$J,358.3,16889,2)
+110 ;;=^5015820
+111 ;;^UTILITY(U,$J,358.3,16890,0)
+112 ;;=A56.11^^61^777^39
+113 ;;^UTILITY(U,$J,358.3,16890,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,16890,1,3,0)
+116 ;;=3^Inflammatory Disease Chlamydial Female Pelvic
+117 ;;^UTILITY(U,$J,358.3,16890,1,4,0)
+118 ;;=4^A56.11
+119 ;;^UTILITY(U,$J,358.3,16890,2)
+120 ;;=^5000342
+121 ;;^UTILITY(U,$J,358.3,16891,0)
+122 ;;=N73.5^^61^777^67
+123 ;;^UTILITY(U,$J,358.3,16891,1,0)
+124 ;;=^358.31IA^4^2
